DISORDERS OF THE CLOTTING SYSTEM
1. The intrinsic pathway is best assessed by measuring
a. Prothrombin time
b. Activated partial thromboplastin time (aPTT)
c. Platelet count
d. Bleeding time
2. Pallor in the conjunctiva, nails, or palmar creases is a physical examination finding that suggests
a. Systemic lupus erythematosus
b. Hypothyroidism
c. Anemia
d. Hemolysis
3. Chemistry profile results that suggest hemolysis include an increased level of
a. Lactate dehydrogenase
b. Direct bilirubin
c. Creatinine
d. Alkaline phosphatase
4. One cause of an abnormally low fibrinogen level is
a. Aspirin overdose
b. Leukemia
c. Christmas disease
d. Disseminated intravascular coagulation
5. A prolonged aPTT is a characteristic of
a. Idiopathic thrombocytopenic purpura
b. Hypersplenism
c. Factor VIII dysfunction
d. Severe vitamin B12 deficiency
6. The most common systemic disorder that causes platelet dysfunction is
a. HIV infection
b. Uremia
c. Rheumatoid arthritis
d. Lymphoma
PRIMARY PERITONEAL CANCER
7. The percent of ovarian cancer cases that are actually primary peritoneal cancer (PPC) is estimated to be
a. 1%
b. 10%
c. 20%
d. 30%
8. The most frequently occurring symptom of PPC is
a. Change in bowel habits
b. Nausea/vomiting
c. Dyspepsia
d. Abdominal pain
9. The most common physical examination finding associated with PPC is
a. Ascites
b. Menorrhagia
c. Palpable pelvic mass
d. Vaginal discharge
10. In more than 90% of patients with PPC, the marker that becomes elevated is
a. ERBB2 gene overexpression
b. Carcinoembryonic antigen level
c. Cancer antigen 125 level
d. Alpha-fetoprotein level
11. A common site of metastases for PPC is the
a. Bone
b. Liver
c. Colon
d. Bladder
12. A common initial chemotherapeutic agent for PPC is
a. Methotrexate
b. Vincristine
c. Bleomycin
d. Carboplatin
CME EXPIRATION DATE: DECEMBER 2008
Successful completion of the self-assessment is required to earn Category I CME credit. Successful completion is defined as a cumulative score of at least 70% correct.